DRKS00022458招募中不适用
Assessment of soluble urokinase plasminogen receptor activator (suPAR) in patients admitted to the intensive care unit in a real-world setting – the SICURS study - A prospective, single center observational study - SICURS
niversitätsklinik für Innere Medizin, Medizinische Universität Graz0 个研究点目标入组 240 人开始时间: 2020年7月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 120 Years（—）
- 性别
- All
入选标准
- •Adult (>= 18 years) patients
- •- Admission to the IC
排除标准
- •- Declined to participate
- •- Patient in palliative care or comfort terminal care only
- •- Age < 18
研究者
相似试验
已完成
不适用
Estimation of Supar and YKL-40 in generalized periodontitis and diabetes.CTRI/2022/07/044107Bhavana Vunnam80
已完成
不适用
Urokinase Plasminogen Activator System in Benign Prostatic HyperplasiaBPHNCT00407329Queen's University30
Unknown
不适用
Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .Behçet DiseaseNCT04105439Assiut University90
尚未招募
不适用
Determination of Salivary Soluble Urokinase Plasminogen Activator Receptor (SuPAR), Hypoxia-inducible Factor-1 Alpha (HIF-1α), E-cadherin, Galectin 3, IL-4, IL-10 and TNF-α Levels in Individuals With Different Degrees of Periodontal DiseasePeriodontal DiseasesPeriodontitisNCT06430450Karamanoğlu Mehmetbey University80
已完成
不适用
suPAR is a Potential Biomarker of in Chronic Periodontitis Through the Impact of Post-radiotherapy on HNCs PatientsHead and Neck CancerChronic PeriodontitisComplications RadiotherapyNCT06481059Al-Maarif University College150